Prime Medicine (PRME) Amortizatization of Intangibles (2021 - 2026)

Prime Medicine (PRME) has 6 years of Amortizatization of Intangibles data on file, last reported at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 17.82% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (down 11.31% YoY), and the FY2025 full-year result was $9.7 million, down 21.51% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $2.8 million, up from $2.6 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $9.9 million in Q4 2022 and bottomed at -$2.0 million in Q2 2022.
• The 5-year median for Amortizatization of Intangibles is $2.4 million (2025), against an average of $2.8 million.
• Peak annual rise in Amortizatization of Intangibles reached 2004.7% in 2023, while the deepest fall reached 66.15% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at $9.9 million in 2022, then sank by 66.15% to $3.3 million in 2023, then tumbled by 34.05% to $2.2 million in 2024, then advanced by 17.89% to $2.6 million in 2025, then gained by 9.22% to $2.8 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $2.8 million (Q1 2026), $2.6 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison